News Recap: Wesco Aircraft Holdings, Inc. (NYSE:WAIR), Auris Medical Holding AG (NASDAQ:EARS)


Wesco Aircraft Holdings, Inc. (NYSE:WAIR)

Wesco Aircraft Holdings, Inc. (NYSE:WAIR) represented a move of 2.91 percent or $-0.25 per share and closed its previous day trading session at $8.85. 1.61 Million Shares were traded in the last trading session with an Average Volume of 711.13 Million Shares. The stock currently has a Market Capitalization of 877.29 Million.

Wesco Aircraft Holdings, Inc. distributes and provides supply chain management services to the global aerospace industry. It offers inventory of aerospace parts, including hardware, bearings, tools, electronic components and machined parts. The Company’s services range from traditional distribution to the management of supplier relationships, quality assurance, kitting, just-in-time delivery and point-of-use inventory management. Wesco Aircraft Holdings, Inc. is headquartered in Valencia, California.

The stock traded between $ 6.05 and $12.65 over 1-Year time period showing its price to sales ratio of 0.61. Wesco Aircraft Holdings, Inc. (NYSE:WAIR) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.

Right now, the stock has a 50-Day Simple Moving Average of $22.31 and 200-Day Simple Moving Average of $0.61. Its Price to Free Cash Flow is 0 and Price to Book of 1.35.

Analyst’s recommended the stock as 3 where 1 represents Strong Buy and 5 represents Sell.

In the last Quarter, Wesco Aircraft Holdings, Inc. (NYSE:WAIR) reported its Actual EPS of $0.15/share. The analysts offering Earnings Estimates for the company were believing that Wesco Aircraft Holdings, Inc. could bring EPS of $0.13/share. The difference between Actual EPS and Estimated EPS was 0.02 Percent. Thus showing an Earnings Surprise of 15.4 Percent.

Auris Medical Holding AG (NASDAQ:EARS)

In the last trading session, Auris Medical Holding AG (NASDAQ:EARS) added its value by -9.01% closing at the price of $0.3. The stock currently has market capitalization of 16.4 Million, with average volume of 1.39 Million shares.

Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Auris Medical Holding AG (NASDAQ:EARS) is showing beta of 0.41. This particular value of beta suggests that Auris Medical Holding AG (NASDAQ:EARS) has historically moved 41% for every 100% move in the benchmark, based on price level.

EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Auris Medical Holding AG (NASDAQ:EARS) is at $-0.68.

The stock currently has RSI of 36.37. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.

Auris Medical Holding AG is a biopharmaceutical company. It focuses on developing therapies for the treatment of hearing loss and tinnitus. The Company has two projects in advanced clinical development: AM-101 for the treatment of acute inner ear tinnitus and AM-111 for the treatment of acute inner ear hearing loss. Auris Medical Holding AG is headquartered in Zug, Switzerland.

Auris Medical Holding AG (NASDAQ:EARS) topped its 52-week high price of $1.060 on 02/24/17 and 52-Week Low Price of $0.250 on 02/09/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 15.83% and monthly volatility of 10.09% respectively.